US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition ...
Reuters15d
Merck to stop lung condition drug study early due to strong efficacy data
Jan 30 (Reuters) - Merck (MRK.N), opens new tab plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in ...
T3N19d
Instagram-Profil-Update: 3:4 statt Quadrat – Was bedeutet das für dein Profil?
Das Instagram-Profil gilt für Millionen von Creatorn als zentraler Bezugspunkt ihrer Social-Media-Erfahrung. Und gerade für dieses gibt es jetzt ein riesiges Update, das dem Instagram-Chef Adam ...
Reuters21d
Merck, Eisai's combination drug fails in late-stage trial for esophageal cancer
Jan 24 (Reuters) - Merck (MRK.N), opens new tab and Japan-based Eisai (4523.T), opens new tab said on Friday a combination of their therapies failed to extend the lives of patients with a type of ...
The New York Times23d
Kennedy Would Keep Stake in HPV Vaccine Suit if Confirmed
Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...
Seeking Alpha25d
Despite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck Partnership
Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.
U.S. News & World Report26d
Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck
Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...
Forbes27d
What’s In Store For Merck Stock In 2025?
Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...
Business Insider27d
Merck price target lowered to $122 from $130 at Guggenheim
Guggenheim analyst Vamil Divan lowered the firm’s price target on Merck (MRK) to $122 from $130 and keeps a Buy rating on the shares. The firm is updating its global biopharma coverage forecasts ...
Purdue University28d
Purdue aims to speed evolution of pharma manufacturing in collaboration with Lilly and Merck
WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...
Yahoo Finance28d
Merck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?
Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...